Description

ENAPRIL-HT TAB (1X15)

Indications

ENAPRIL-HT TAB is a combination medication primarily indicated for the treatment of hypertension (high blood pressure) in adults. It is often prescribed for patients who require multiple antihypertensive agents to achieve optimal blood pressure control. Additionally, this medication may be utilized in the management of heart failure and to reduce the risk of cardiovascular events in patients with certain risk factors.

Mechanism of Action

ENAPRIL-HT TAB contains two active ingredients: enalapril and hydrochlorothiazide. Enalapril is an angiotensin-converting enzyme (ACE) inhibitor, which works by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. This action leads to vasodilation, reduced blood pressure, and decreased workload on the heart.

Hydrochlorothiazide is a thiazide diuretic that promotes the excretion of sodium and water through the kidneys. By reducing blood volume, hydrochlorothiazide further aids in lowering blood pressure. The combination of these two mechanisms provides a synergistic effect, resulting in more effective blood pressure management than either component alone.

Pharmacological Properties

ENAPRIL-HT TAB exhibits pharmacokinetic properties that allow for effective management of hypertension. Enalapril is rapidly absorbed after oral administration, with peak plasma concentrations occurring within one hour. It is converted to its active form, enalaprilat, in the liver. The half-life of enalaprilat is approximately 11 hours, allowing for once-daily dosing in most patients.

Hydrochlorothiazide is also well-absorbed, with peak plasma concentrations reached within 2 to 4 hours post-administration. Its diuretic effects can last for up to 12 hours. The combination of these two agents results in a sustained antihypertensive effect, which is crucial for long-term management of hypertension.

Contraindications

ENAPRIL-HT TAB is contraindicated in patients with a known hypersensitivity to enalapril, hydrochlorothiazide, or any of the excipients in the formulation. It should not be used in patients with a history of angioedema related to previous ACE inhibitor therapy. Additionally, the medication is contraindicated in patients with severe renal impairment, anuria, or electrolyte imbalances, particularly hypokalemia.

Side Effects

Common side effects associated with ENAPRIL-HT TAB may include dizziness, headache, fatigue, and gastrointestinal disturbances such as nausea or diarrhea. More serious side effects can occur, including hypotension, renal impairment, hyperkalemia, and angioedema. Patients should be monitored for these adverse effects, especially during the initiation of therapy or when the dosage is adjusted.

In rare cases, hydrochlorothiazide may cause electrolyte imbalances, leading to hypokalemia, hyponatremia, or hypercalcemia. Regular monitoring of serum electrolytes is recommended for patients on this medication.

Dosage and Administration

The recommended starting dose of ENAPRIL-HT TAB for most adults is one tablet taken orally once daily. Depending on the patient’s response and blood pressure levels, the dosage may be adjusted by the healthcare provider. It is essential for patients to adhere to the prescribed dosage and schedule to achieve optimal therapeutic outcomes.

ENAPRIL-HT TAB can be taken with or without food. Patients should be advised to swallow the tablet whole and not to crush or chew it. If a dose is missed, it should be taken as soon as remembered, but if it is close to the time of the next dose, the missed dose should be skipped. Patients should not double the dose to catch up.

Interactions

ENAPRIL-HT TAB may interact with several medications, which can alter its effectiveness or increase the risk of adverse effects. Notable drug interactions include non-steroidal anti-inflammatory drugs (NSAIDs), which may reduce the antihypertensive effect of enalapril and increase the risk of renal impairment.

Other medications that may interact with ENAPRIL-HT TAB include potassium-sparing diuretics, potassium supplements, and salt substitutes containing potassium, as they can lead to hyperkalemia. Patients should inform their healthcare provider of all medications, supplements, and herbal products they are taking to avoid potential interactions.

Precautions

Before initiating treatment with ENAPRIL-HT TAB, healthcare providers should assess the patient’s medical history, including any history of renal disease, liver dysfunction, or electrolyte imbalances. Caution is advised when prescribing this medication to patients with a history of heart failure, as it may exacerbate renal function in some individuals.

Patients should be monitored for signs of hypotension, particularly after the first dose or when increasing the dose. Regular follow-up appointments are essential to evaluate blood pressure response and to monitor renal function and electrolyte levels throughout the duration of therapy.

Clinical Studies

Clinical studies have demonstrated the efficacy of ENAPRIL-HT TAB in reducing blood pressure in patients with essential hypertension. In a randomized controlled trial, patients receiving the combination therapy experienced a significant reduction in systolic and diastolic blood pressure compared to those receiving monotherapy with either enalapril or hydrochlorothiazide alone.

Long-term studies have also indicated that the use of ENAPRIL-HT TAB can lead to improved cardiovascular outcomes, including a reduction in the incidence of heart failure and other cardiovascular events. These findings support the use of this combination therapy in patients with multiple risk factors for cardiovascular disease.

Conclusion

ENAPRIL-HT TAB is an effective combination medication for the management of hypertension and related cardiovascular conditions. Its dual action as an ACE inhibitor and thiazide diuretic provides a comprehensive approach to blood pressure control. While generally well-tolerated, it is essential for patients to be aware of potential side effects and drug interactions. Regular monitoring and adherence to prescribed dosages are crucial for achieving optimal therapeutic outcomes.